Oct. 17, 2023

An article by the Associated Press (AP) published Oct. 17 considers, “Are 3D mammograms better than standard 2D imaging for catching advanced [breast] cancers?” The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), discussed in the article and managed daily by the American College of Radiology® (ACR®) Center for Research and Innovation, intends to find out.

The National Cancer Institute-funded TMIST study — one of the most diverse cancer screening trials in history — already has nearly 93,000 of the planned 128,000 participants enrolled. The AP reports, “At the U.S. study sites, 21% of study participants are Black women — that’s higher than a typical cancer treatment study, in which 9% of participants are Black.”

The AP quotes Etta Pisano, MD, FACR, ACR Chief Research Officer, who shared that the study, led by the ECOG-ACRIN Cancer Research Group, “added more international sites to enhance the trial’s diversity, particularly for Hispanic and Asian women.”


Related ACR News

  • ACR Advises Changes to Washington State PAD Report

    ACR urged the WA State Health Technology Clinical Committee to not act on the draft report that would limit coverage of endovascular procedures for PAD.

    Read more
  • Take Action: Contact Your US Senators to Cosponsor ROOT Act

    Support the ROOT Act—Senate cosponsors needed to fix CMS issues with imaging AUC under PAMA. College member advocacy is key.

    Read more
  • Career Growth Through Volunteer Work

    Dr. Bryant Chang shares how early involvement with his state chapter led to launching a medical student section, mentorship program and a symposium.

    Read more